Biserka Relić
Impact in
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Osteoarthritis Treatment and Mechanisms 8
- Co-authors
- Michel Malaise (19 shared papers)Vincent Bours (6 shared papers)Marie‐Paule Merville (6 shared papers)Dominique de Seny (14 shared papers)Alain Chariot (3 shared papers)Sophie Neuville (11 shared papers)Edith Charlier (8 shared papers)Mohamed Bentires‐Alj (2 shared papers)
- Journals
- Osteoarthritis and Cartilage (4 papers)Laboratory Investigation (2 papers)Journal of Biological Chemistry (2 papers)Oncotarget (2 papers)Oncogene (2 papers)
- Partner nations
- BelgiumSwitzerlandFrance
In The Last Decade
Biserka Relić
24 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Rheumatology 405
- Cancer Research 311
- Pharmacology 210
- Oncology 327
- Genetics 124
Countries citing papers authored by Biserka Relić
This map shows the geographic impact of Biserka Relić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biserka Relić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biserka Relić more than expected).
Fields of papers citing papers by Biserka Relić
This network shows the impact of papers produced by Biserka Relić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biserka Relić. The network helps show where Biserka Relić may publish in the future.
Co-authors
The 25 scholars most cited alongside Biserka Relić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 379 | |
| 2 | 2016 | 271 | |
| 3 | 2010 | 99 | |
| 4 | 2001 | 69 | |
| 5 | 2013 | 69 | |
| 6 | 2004 | 62 | |
| 7 | 1999 | 43 | |
| 8 | 2009 | 43 | |
| 9 | 2004 | 40 | |
| 10 | 2015 | 40 | |
| 11 | 2002 | 40 | |
| 12 | 2005 | 37 | |
| 13 | 2002 | 17 | |
| 14 | 2015 | 14 | |
| 15 | 2011 | 14 | |
| 16 | 2006 | 14 | |
| 17 | 2014 | 13 | |
| 18 | 2016 | 13 | |
| 19 | 2016 | 7 | |
| 20 | 2018 | 5 |
About Biserka Relić
Biserka Relić is a scholar working on Molecular Biology, Rheumatology, Epidemiology, Oncology and Cancer Research, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (8 papers), Inflammatory mediators and NSAID effects (4 papers), NF-κB Signaling Pathways (4 papers), Regulation of Appetite and Obesity (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Rheumatology (405 citations), Cancer Research (311 citations), Pharmacology (210 citations), Oncology (327 citations) and Genetics (124 citations). Biserka Relić has collaborated with scholars based in Belgium, Switzerland and France. Frequent co-authors include Michel Malaise, Vincent Bours, Marie‐Paule Merville, Dominique de Seny, Alain Chariot, Sophie Neuville, Edith Charlier, Mohamed Bentires‐Alj, Jacques Gielen and Olivier Malaise. Their work appears in journals such as Osteoarthritis and Cartilage, Laboratory Investigation, Journal of Biological Chemistry, Oncotarget and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.